Citation Impact
Citing Papers
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis
1992
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
2004
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
The smoking problem: A review of the research and theory in behavioral risk modification.
1980
Oral anticoagulants in patients with coronary artery disease
2003
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials
1996
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Long-term survival after transient loss of consciousness
1988
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Improvement in Pulmonary Function and Elastic Recoil after Lung-Reduction Surgery for Diffuse Emphysema
1996
Lung Volume Reduction Surgery for Emphysema
1996
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
1995 Standout
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Airway Mucus Function and Dysfunction
2010 Standout
Warfarin Anticoagulation and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction 11This study was supported by Grant MO1-RR00054 from the General Clinical Research Center, funded by the Division of Research Resources, National Institutes of Health, Bethesda, Maryland. The Studies of Left Ventricular Dysfunction (SOLVD) were funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, with a contribution from Merck, Sharpe and Dohme Pharmaceutical Company, West Point, Pennsylvania.
1998
Disseminated Intravascular Coagulation
1999 Standout
Incidence and Prognosis of Syncope
2002 Standout
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Age-associated accumulation of 8-hydroxydeoxyguanosine in mitochondrial DNA of human diaphragm
1991
Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: A community-wide perspective
1990
Exercise limitation in chronic heart failure: Central role of the periphery
1996
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Age-related Decrease in Respiratory Muscle Mitochondrial Function in Rats
1992
Amplification of Inflammation in Emphysema and Its Association with Latent Adenoviral Infection
2001 Standout
Mucin Is Produced by Clara Cells in the Proximal Airways of Antigen-Challenged Mice
2004
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Circulatory changes in chronic liver disease
1958
ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase
1979 StandoutNatureNobel
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction
1972
The Centrilobular Form of Hypertrophic Emphysema and its Relation to Chronic Bronchitis
1957
Arterial Changes in the Lungs in Cirrhosis of the Liver — Lung Spider Nevi
1966 Standout
Shock Caused by Gram-negative Microorganisms
1964
Hyperventilation and arterial hypoxemia in cirrhosis of the liver
1960
Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk.
1989
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Isolation and Characterization of Plasma Membranes from Human Blood Platelets
1970
Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
2002 StandoutNobel
Vocal-Cord Dysfunction Presenting as Asthma
1983 Standout
Effects of age on elastic moduli of human lungs
2000
Prognosis after initial myocardial infarction: The Framingham study
1979
Disseminated intravascular coagulation as a possible factor in the pathogenesis of thrombotic microangiopathy (hemolytic-uremic syndrome)
1967
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
2003
The Value of the Autopsy in Three Medical Eras
1983 Standout
Long-term anticoagulant therapy after acute myocardial infarction
1985
Stroke in Patients With Acute Coronary Syndromes
1999
Randomized versus historical controls for clinical trials
1982
Impact of Atrial Fibrillation on the Risk of Death
1998 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
ESTIMATION OF PULMONARY ARTERIOVENOUS SHUNT-FLOW USING INTRAVENOUS INJECTIONS OF T-1824 DYE AND KR85*
1960
Oral anticoagulant in patients surviving myocardial infarction
1983
A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for Severe Emphysema
2003 Standout
Improving Drug-Therapy Decisions through Educational Outreach
1983 Standout
The Relationship Between Airway Resistance, Airway Conductance and Lung Volume in Subjects of Different Age and Body Size12
1958 Standout
Inhibition by Oral N-Acetylcysteine of Cigarette Smoke-Induced “Bronchitis” in the Rat
1986
Multifactorial Index of Cardiac Risk in Noncardiac Surgical Procedures
1977 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
VENO‐ARTERIAL SHUNTING OF BLOOD IN CHRONIC LIVER DISEASE
1960
Cirrhosis of the Liver and Decreased Arterial Oxygen Saturation
1961
Antithrombotic agents in coronary artery disease
1989
TISSUE DISTRIBUTION OF I131 LABELED HUMAN SERUM ALBUMIN FOLLOWING INTRAVENOUS ADMINISTRATION
1955 StandoutNobel
Blood volume in health and disease.
1954
Idiopathic Pulmonary Fibrosis
1976
DISTRIBUTION AND METABOLISM OF I131 LABELED HUMAN SERUM ALBUMIN IN CONGESTIVE HEART FAILURE WITH AND WITHOUT PROTEINURIA
1955 StandoutNobel
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1997 Standout
Prognostic Factors in Acute Pulmonary Edema
1986
A NEW METHOD FOR MEASURING AIRWAY RESISTANCE IN MAN USING A BODY PLETHYSMOGRAPH: VALUES IN NORMAL SUBJECTS AND IN PATIENTS WITH RESPIRATORY DISEASE 1
1956 Standout
Is the Dose of Warfarin Prescribed by American Physicians Unnecessarily High?
1987
Attenuation of the Ventilatory and Heart Rate Responses to Hypoxia and Hypercapnia with Aging in Normal Men
1973
The Flow Volume Loop: Normal Standards and Abnormalities in Chronic Obstructive Pulmonary Disease
1973
Acute myocardial infarction. Prognostic value of white blood cell count and blood glucose level
1975
Pulmonary venoarterial shunting in hepatic cirrhosis
1961
Significance of the relationship between lung recoil and maximum expiratory flow.
1967
SOURCES OF VENOARTERIAL ADMIXTURE IN PORTAL HYPERTENSION*
1963
BLOOD VOLUME ALTERATIONS IN CONGESTIVE HEART FAILURE
1954 StandoutNobel
The Autopsy: Its Decline and a Suggestion for Its Revival
1978
A NEW CORONARY PROGNOSTIC INDEX
1969
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Evaluation and outcome of emergency room patients with transient loss of consciousness
1982
A Prospective Evaluation and Follow-up of Patients with Syncope
1983 Standout
Complexity and contradiction in clinical trial research
1987
Works of Richard V. Ebert being referenced
The Bronchiolar Epithelium in Cigarette Smokers
2015
Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study.
1969
The Mechanism and Treatment of Shock Associated with Infection
1956
The mechanics of pulmonary ventilation in normal subjects and in patients with emphysema
1954
Cessation of Cigarette Smoking and Pulmonary Disease
1978
Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial.
1973
Pathogenesis of Pulmonary Emphysema
1963
A CRITICAL COMPARISON OF THE T-1824 DYE AND IODINATED ALBUMIN METHODS FOR PLASMA VOLUME MEASUREMENT 1
1953
Initial myocardial infarction among 503 Veterans
1960
Inital arguments
1974
MICROELECTROPHORESIS OF BLOOD PLATELETS AND THE EFFECTS OF DEXTRAN*†
1959
Syncope
1963
Regional Pulmonary Function Evaluation Using Xenon 133, a Scintillation Camera, and Computer
1969
THE EFFECTS OF DEXTRAN IN NORMOVOLEMIC AND OLIGEMIC SUBJECTS 1
1953
Long-Term Anticoagulant Therapy After Myocardial Infarction
1969
Elasticity of the Lung in Pulmonary Emphysema
1968
The mechanics of pulmonary ventilation in patients with heart disease
1954
Mucus secretion by the epithelium of the bronchioles of cigarette smokers
1981
The determinations of blood flow through nonventilated portions of the normal and diseased lung.
1953
The elastic properties of the lung in normal men and in patients with chronic pulmonary emphysema.
1952
The elastic properties of the lungs in the aged.
1958
Use of Anticoagulants in Acute Myocardial Infarction
1972
The bronchiolar epithelium in cigarette smokers. Observations with the scanning electron microscope.
1975